作者
Jack A Terrett, Huifen Chen, Daniel G Shore, Elisia Villemure, Robin Larouche-Gauthier, Martin Dery, Francis Beaumier, Lea Constantineau-Forget, Chantal Grand-Maitre, Luce Lepissier, Stephane Ciblat, Claudio Sturino, Yong Chen, Baihua Hu, Aijun Lu, Yunli Wang, Andrew P Cridland, Stuart I Ward, David H Hackos, Rebecca M Reese, Shannon D Shields, Jun Chen, Alessia Balestrini, Lorena Riol-Blanco, Wyne P Lee, John Liu, Eric Suto, Xiumin Wu, Juan Zhang, Justin Q Ly, Hank La, Kevin Johnson, Matt Baumgardner, Kang-Jye Chou, Alexis Rohou, Lionel Rouge, Brian S Safina, Steven Magnuson, Matthew Volgraf
发表日期
2021/3/22
期刊
Journal of Medicinal Chemistry
卷号
64
期号
7
页码范围
3843-3869
出版商
American Chemical Society
简介
Transient receptor potential ankyrin 1 (TRPA1) is a nonselective calcium-permeable ion channel highly expressed in the primary sensory neurons functioning as a polymodal sensor for exogenous and endogenous stimuli and has generated widespread interest as a target for inhibition due to its implication in neuropathic pain and respiratory disease. Herein, we describe the optimization of a series of potent, selective, and orally bioavailable TRPA1 small molecule antagonists, leading to the discovery of a novel tetrahydrofuran-based linker. Given the balance of physicochemical properties and strong in vivo target engagement in a rat AITC-induced pain assay, compound 20 was progressed into a guinea pig ovalbumin asthma model where it exhibited significant dose-dependent reduction of inflammatory response. Furthermore, the structure of the TRPA1 channel bound to compound 21 was determined via …
引用总数